An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
Sympathomimetic, vasoconstrictor agent.
Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.
Analogs or derivatives of AMPHETAMINE. Many are sympathomimetics and central nervous system stimulators causing excitation, vasopressin, bronchodilation, and to varying degrees, anorexia, analepsis, nasal decongestion, and some smooth muscle relaxation.
Detection of drugs that have been abused, overused, or misused, including legal and illegal drugs. Urine screening is the usual method of detection.
A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed.
Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.
A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds.
Drugs used for their effects on serotonergic systems. Among these are drugs that affect serotonin receptors, the life cycle of serotonin, and the survival of serotonergic neurons.
The application of TOXICOLOGY knowledge to questions of law.
Drugs obtained and often manufactured illegally for the subjective effects they are said to produce. They are often distributed in urban areas, but are also available in suburban and rural areas, and tend to be grossly impure and may cause unexpected toxicity.
A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed)
A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry.
Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.

3,4-Methylenedioxyamphetamine (MDA) is a psychoactive drug that belongs to the amphetamine class. It is also known as "ecstasy" or "molly." MDA acts as a stimulant, hallucinogen, and entactogen, which means it can produce feelings of increased energy, emotional warmth, and empathy.

MDA is illegal in many countries, including the United States, due to its potential for abuse and the risk of serious adverse effects. Some of the negative consequences associated with MDA use include nausea, vomiting, muscle tension, teeth grinding, increased heart rate and blood pressure, and hyperthermia (elevated body temperature). In high doses or when used in combination with other substances, MDA can cause seizures, coma, and even death.

It is important to note that the use of illegal drugs like MDA carries significant legal and health risks. If you are concerned about your own or someone else's drug use, it is recommended that you seek help from a qualified healthcare professional.

N-Methyl-3,4-methylenedioxyamphetamine (also known as MDA) is a synthetic psychoactive drug that belongs to the class of amphetamines. It acts as a central nervous system stimulant and hallucinogen. Chemically, it is a derivative of amphetamine with an additional methylenedioxy ring attached to the 3,4 positions on the aromatic ring. MDA is known for its empathogenic effects, meaning that it can produce feelings of empathy, emotional openness, and euphoria in users. It has been used recreationally as a party drug and at raves, but it also has potential therapeutic uses. However, MDA can have serious side effects, including increased heart rate and blood pressure, hyperthermia, dehydration, and in some cases, serotonin syndrome. As with other psychoactive drugs, MDA should only be used under medical supervision and with a clear understanding of its potential risks and benefits.

Deoxyepinephrine is not a recognized or established medical term or concept in the field of pharmacology, physiology, or clinical medicine. It appears to be a variation or misspelling of "deoxyepinephrines," which refers to a group of biogenic amines that are structurally related to catecholamines (such as epinephrine and norepinephrine) but lack a hydroxyl group (-OH) in the beta-carbon position of their side chain.

Deoxyepinephrines have been studied in laboratory settings for their potential roles in various physiological processes, such as neurotransmission and vasoconstriction, but they are not commonly used or discussed in clinical contexts. Therefore, there is no established medical definition for "deoxyepinephrine" as a standalone term.

Hallucinogens are a class of psychoactive substances that alter perception, mood, and thought, often causing hallucinations, which are profound distortions in a person's perceptions of reality. These substances work by disrupting the normal functioning of the brain, particularly the parts that regulate mood, sensory perception, sleep, hunger, and sexual behavior.

Hallucinogens can be found in various forms, including plants, mushrooms, and synthetic compounds. Some common examples of hallucinogens include LSD (d-lysergic acid diethylamide), psilocybin (found in certain species of mushrooms), DMT (dimethyltryptamine), and ayahuasca (a plant-based brew from South America).

The effects of hallucinogens can vary widely depending on the specific substance, the dose, the individual's personality, mood, and expectations, and the environment in which the drug is taken. These effects can range from pleasant sensory experiences and heightened emotional awareness to terrifying hallucinations and overwhelming feelings of anxiety or despair.

It's important to note that hallucinogens can be dangerous, particularly when taken in high doses or in combination with other substances. They can also cause long-term psychological distress and may trigger underlying mental health conditions. As such, they should only be used under the guidance of a trained medical professional for therapeutic purposes.

Amphetamines are a type of central nervous system stimulant drug that increases alertness, wakefulness, and energy levels. They work by increasing the activity of certain neurotransmitters (chemical messengers) in the brain, such as dopamine and norepinephrine. Amphetamines can be prescribed for medical conditions such as attention deficit hyperactivity disorder (ADHD) and narcolepsy, but they are also commonly abused for their ability to produce euphoria, increase confidence, and improve performance in tasks that require sustained attention.

Some common examples of amphetamines include:

* Adderall: a combination of amphetamine and dextroamphetamine, used to treat ADHD and narcolepsy
* Dexedrine: a brand name for dextroamphetamine, used to treat ADHD and narcolepsy
* Vyvanse: a long-acting formulation of lisdexamfetamine, a prodrug that is converted to dextroamphetamine in the body, used to treat ADHD

Amphetamines can be taken orally, snorted, smoked, or injected. Long-term use or abuse of amphetamines can lead to a number of negative health consequences, including addiction, cardiovascular problems, malnutrition, mental health disorders, and memory loss.

Substance abuse detection refers to the process of identifying the use or misuse of psychoactive substances, such as alcohol, illicit drugs, or prescription medications, in an individual. This can be done through various methods, including:

1. Physical examination: A healthcare professional may look for signs of substance abuse, such as track marks, enlarged pupils, or unusual behavior.
2. Laboratory tests: Urine, blood, hair, or saliva samples can be analyzed to detect the presence of drugs or their metabolites. These tests can provide information about recent use (hours to days) or longer-term use (up to several months).
3. Self-report measures: Individuals may be asked to complete questionnaires or interviews about their substance use patterns and behaviors.
4. Observational assessments: In some cases, such as in a treatment setting, healthcare professionals may observe an individual's behavior over time to identify patterns of substance abuse.

Substance abuse detection is often used in clinical, workplace, or legal settings to assess individuals for potential substance use disorders, monitor treatment progress, or ensure compliance with laws or regulations.

Methamphetamine is a powerful, highly addictive central nervous system stimulant that affects brain chemistry, leading to mental and physical dependence. Its chemical formula is N-methylamphetamine, and it is structurally similar to amphetamine but has additional methyl group, which makes it more potent and longer-lasting.

Methamphetamine exists in various forms, including crystalline powder (commonly called "meth" or "crystal meth") and a rocklike form called "glass." It can be taken orally, snorted, smoked, or injected after being dissolved in water or alcohol.

Methamphetamine use leads to increased levels of dopamine, a neurotransmitter responsible for reward, motivation, and reinforcement, resulting in euphoria, alertness, and energy. Prolonged use can cause severe psychological and physiological harm, including addiction, psychosis, cardiovascular issues, dental problems (meth mouth), and cognitive impairments.

Designer drugs are synthetic or chemically altered substances that are designed to mimic the effects of controlled substances. They are often created in clandestine laboratories and marketed as legal alternatives to illegal drugs. These drugs are called "designer" because they are intentionally modified to avoid detection and regulation by law enforcement agencies and regulatory bodies.

Designer drugs can be extremely dangerous, as their chemical composition is often unknown or only partially understood. They may contain potentially harmful impurities or variations that can lead to unpredictable and sometimes severe health consequences. Examples of designer drugs include synthetic cannabinoids (such as "Spice" or "K2"), synthetic cathinones (such as "bath salts"), and novel psychoactive substances (NPS).

It is important to note that while some designer drugs may be legal at the time they are manufactured and sold, their possession and use may still be illegal under federal or state laws. Additionally, many designer drugs have been made illegal through scheduling by the Drug Enforcement Administration (DEA) or through legislation specifically targeting them.

Gas Chromatography-Mass Spectrometry (GC-MS) is a powerful analytical technique that combines the separating power of gas chromatography with the identification capabilities of mass spectrometry. This method is used to separate, identify, and quantify different components in complex mixtures.

In GC-MS, the mixture is first vaporized and carried through a long, narrow column by an inert gas (carrier gas). The various components in the mixture interact differently with the stationary phase inside the column, leading to their separation based on their partition coefficients between the mobile and stationary phases. As each component elutes from the column, it is then introduced into the mass spectrometer for analysis.

The mass spectrometer ionizes the sample, breaks it down into smaller fragments, and measures the mass-to-charge ratio of these fragments. This information is used to generate a mass spectrum, which serves as a unique "fingerprint" for each compound. By comparing the generated mass spectra with reference libraries or known standards, analysts can identify and quantify the components present in the original mixture.

GC-MS has wide applications in various fields such as forensics, environmental analysis, drug testing, and research laboratories due to its high sensitivity, specificity, and ability to analyze volatile and semi-volatile compounds.

Serotonin agents are a class of drugs that work on the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT) in the brain and elsewhere in the body. They include several types of medications such as:

1. Selective Serotonin Reuptake Inhibitors (SSRIs): These drugs block the reabsorption (reuptake) of serotonin into the presynaptic neuron, increasing the availability of serotonin in the synapse to interact with postsynaptic receptors. SSRIs are commonly used as antidepressants and include medications such as fluoxetine, sertraline, and citalopram.
2. Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): These drugs block the reabsorption of both serotonin and norepinephrine into the presynaptic neuron, increasing the availability of these neurotransmitters in the synapse. SNRIs are also used as antidepressants and include medications such as venlafaxine and duloxetine.
3. Serotonin Receptor Agonists: These drugs bind to and activate serotonin receptors, mimicking the effects of serotonin. They are used for various indications, including migraine prevention (e.g., sumatriptan) and Parkinson's disease (e.g., pramipexole).
4. Serotonin Receptor Antagonists: These drugs block serotonin receptors, preventing the effects of serotonin. They are used for various indications, including nausea and vomiting (e.g., ondansetron) and as mood stabilizers in bipolar disorder (e.g., olanzapine).
5. Serotonin Synthesis Inhibitors: These drugs block the enzymatic synthesis of serotonin, reducing its availability in the brain. They are used as antidepressants and include medications such as monoamine oxidase inhibitors (MAOIs) like phenelzine and tranylcypromine.

It's important to note that while these drugs all affect serotonin, they have different mechanisms of action and are used for various indications. It's essential to consult a healthcare professional before starting any new medication.

Forensic Toxicology is a branch of toxicology that applies scientific methods and techniques to investigate and provide information about the presence, identity, concentration, and effects of drugs, poisons, or other chemicals in biological specimens (such as blood, urine, tissues) within a legal context. It is often used in criminal investigations, medical examinations, and workplace drug testing to determine the cause of death, poisoning, impairment, or other health effects related to exposure to toxic substances. Forensic toxicologists may also provide expert testimony in court based on their findings.

"Street drugs" is a colloquial term rather than medical jargon, but it generally refers to illegal substances or medications that are used without a prescription. These can include a wide variety of drugs such as marijuana, cocaine, heroin, methamphetamines, ecstasy, LSD, and many others. They are called "street drugs" because they are often bought and sold on the street or in clandestine settings, rather than through legitimate pharmacies or medical professionals. It's important to note that these substances can be highly dangerous and addictive, with serious short-term and long-term health consequences.

Amphetamine is a central nervous system stimulant drug that works by increasing the levels of certain neurotransmitters (chemical messengers) in the brain, such as dopamine and norepinephrine. It is used medically to treat conditions such as attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity, due to its appetite-suppressing effects.

Amphetamines can be prescribed in various forms, including tablets, capsules, or liquids, and are available under several brand names, such as Adderall, Dexedrine, and Vyvanse. They are also known by their street names, such as speed, uppers, or wake-ups, and can be abused for their euphoric effects and ability to increase alertness, energy, and concentration.

Long-term use of amphetamines can lead to dependence, tolerance, and addiction, as well as serious health consequences, such as cardiovascular problems, mental health disorders, and malnutrition. It is essential to use amphetamines only under the supervision of a healthcare provider and follow their instructions carefully.

Central nervous system (CNS) stimulants are a class of drugs that increase alertness, attention, energy, and/or mood by directly acting on the brain. They can be prescribed to treat medical conditions such as narcolepsy, attention deficit hyperactivity disorder (ADHD), and depression that has not responded to other treatments.

Examples of CNS stimulants include amphetamine (Adderall), methylphenidate (Ritalin, Concerta), and modafinil (Provigil). These medications work by increasing the levels of certain neurotransmitters, such as dopamine and norepinephrine, in the brain.

In addition to their therapeutic uses, CNS stimulants are also sometimes misused for non-medical reasons, such as to enhance cognitive performance or to get high. However, it's important to note that misusing these drugs can lead to serious health consequences, including addiction, cardiovascular problems, and mental health issues.

Stereoisomerism is a type of isomerism (structural arrangement of atoms) in which molecules have the same molecular formula and sequence of bonded atoms, but differ in the three-dimensional orientation of their atoms in space. This occurs when the molecule contains asymmetric carbon atoms or other rigid structures that prevent free rotation, leading to distinct spatial arrangements of groups of atoms around a central point. Stereoisomers can have different chemical and physical properties, such as optical activity, boiling points, and reactivities, due to differences in their shape and the way they interact with other molecules.

There are two main types of stereoisomerism: enantiomers (mirror-image isomers) and diastereomers (non-mirror-image isomers). Enantiomers are pairs of stereoisomers that are mirror images of each other, but cannot be superimposed on one another. Diastereomers, on the other hand, are non-mirror-image stereoisomers that have different physical and chemical properties.

Stereoisomerism is an important concept in chemistry and biology, as it can affect the biological activity of molecules, such as drugs and natural products. For example, some enantiomers of a drug may be active, while others are inactive or even toxic. Therefore, understanding stereoisomerism is crucial for designing and synthesizing effective and safe drugs.

Mass spectrometry with electrospray ionization (ESI-MS) is an analytical technique used to identify and quantify chemical species in a sample based on the mass-to-charge ratio of charged particles. In ESI-MS, analytes are ionized through the use of an electrospray, where a liquid sample is introduced through a metal capillary needle at high voltage, creating an aerosol of charged droplets. As the solvent evaporates, the analyte molecules become charged and can be directed into a mass spectrometer for analysis.

ESI-MS is particularly useful for the analysis of large biomolecules such as proteins, peptides, and nucleic acids, due to its ability to gently ionize these species without fragmentation. The technique provides information about the molecular weight and charge state of the analytes, which can be used to infer their identity and structure. Additionally, ESI-MS can be interfaced with separation techniques such as liquid chromatography (LC) for further purification and characterization of complex samples.

High-performance liquid chromatography (HPLC) is a type of chromatography that separates and analyzes compounds based on their interactions with a stationary phase and a mobile phase under high pressure. The mobile phase, which can be a gas or liquid, carries the sample mixture through a column containing the stationary phase.

In HPLC, the mobile phase is a liquid, and it is pumped through the column at high pressures (up to several hundred atmospheres) to achieve faster separation times and better resolution than other types of liquid chromatography. The stationary phase can be a solid or a liquid supported on a solid, and it interacts differently with each component in the sample mixture, causing them to separate as they travel through the column.

HPLC is widely used in analytical chemistry, pharmaceuticals, biotechnology, and other fields to separate, identify, and quantify compounds present in complex mixtures. It can be used to analyze a wide range of substances, including drugs, hormones, vitamins, pigments, flavors, and pollutants. HPLC is also used in the preparation of pure samples for further study or use.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

N-methyl-1,3-benzodioxolylbutanamine (MBDB; "Eden"), and 3,4-methylenedioxy-N-methylcathinone (βk-MDMA; "Methylone"). The ... 149 (2-3): 181-92. doi:10.1016/j.forsciint.2004.06.016. PMID 15749360. PiHKAL ("Phenethylamines i Have Known And Loved") by ... ISBN 978-3-03788-700-4. Dr. Matthias Grill, Novel Safrylamine derivates having prodrug properties. Patent WO 2022/053696 Świst ... The base compound of the MDxx class is 3,4-methylenedioxyphenethylamine (MDPEA), and the prototypical agent of this class is 3, ...
1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen)". Arzneimittel- ... "Pizotyline effectively attenuates the stimulus effects of N-methyl-3,4-methylenedioxyamphetamine (MDMA)". Pharmacology, ... 187 (3): 142-146. doi:10.5694/j.1326-5377.2007.tb01170.x. PMID 17680738. S2CID 10357983. Jackson JL, Cogbill E, Santana-Davila ... 56 (4): 276-279. doi:10.1111/j.1600-0447.1977.tb00228.x. PMID 335788. S2CID 6445059. Banki CM (March 1978). "Clinical ...
... methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 41 (6): 1001-5. CiteSeerX 10.1.1.688.9559. doi:10.1021/ ... Thus, while several-fold less potent than its analogues 2-methyl-MDA and 5-methyl-MDA, and approximately half as potent as MDA ... 6-Methyl-3,4-methylenedioxyamphetamine (6-Methyl-MDA) is an entactogen and psychedelic drug of the amphetamine class. It was ... 6-Methyl-MDA has IC50 values of 783 nM, 28,300 nM, and 4,602 nM for inhibiting the reuptake of serotonin, dopamine, and ...
... methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 41 (6): 1001-5. doi:10.1021/jm9705925. PMID 9526575. PIHKAL ... 2-Methyl-MDA is also much more potent than MDA, but is not quite as potent as 5-methyl-MDA. 6-methyl-MDMA (also known as Madam- ... 5-Methyl-MDA is not scheduled at the federal level in the United States, but it is possible that 5-Methyl-MDA could legally be ... Recent research has used data on 2-methyl-MDA and 5-methyl-MDA to help guide computer modeling of the serotonin transporter ...
... methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 41 (6): 1001-5. CiteSeerX 10.1.1.688.9559. doi:10.1021/ ... 2-Methyl-MDA is more potent than MDA and 5-methyl-MDA. However, it is slightly more selective for serotonin over dopamine and ... 2-Methyl-3,4-methylenedioxyamphetamine (2-methyl-MDA) is an entactogen[citation needed] and psychedelic[citation needed] drug ... norepinephrine release in comparison to 5-methyl-MDA. Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE (March ...
... and 2-methyl-N-[11C]methyl-4,5-methylenedioxyamphetamine: Synthesis and biodistribution studies". Journal of Radioanalytical ... 5-methylenedioxyamphetamine, is a lesser-known recreational drug of the methamphetamine class, similar in structure to MDMA ( ...
Kronstrand R (October 1996). "Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug ... methylenedioxyamphetamine, two widely distributed street drugs". Rapid Communications in Mass Spectrometry. 12 (12): 779-82. ... "Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- ... ", "Methyl-J"). However, it is more commonly known as a metabolite of the N-alkylated analogues MBDB and ...
5-methylenedioxyamphetamine (5-Methyl-MDA) 3,4-Ethylenedioxy-N-methylamphetamine (EDMA) 4-Methoxyamphetamine (PMA) 4-Methoxy-N- ... 6-Methylenedioxy-N-methyl-2-aminoindane (MDMAI) 6-Chloro-2-aminotetralin (6-CAT) 6-Tetralinyl-2-aminopropane (TAP) 6,7- ... 2-Methyl-3,4-methylenedioxyamphetamine (2-Methyl-MDA) 3-Methoxy-4-methylamphetamine (MMA) 3-Methyl-4, ... "Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan". European Journal of ...
... methyl methacrylates MeSH D02.241.081.069.800.550.450 - methyl methacrylate MeSH D02.241.081.069.800.550.500 - polymethyl ... methyl n-butyl ketone MeSH D02.522.585.175 - acetoacetates MeSH D02.522.585.342 - acetone MeSH D02.522.675.500 - methadyl ... methyl chloride MeSH D02.455.526.439.642 - methylene chloride MeSH D02.455.526.439.659 - mirex MeSH D02.455.526.439.681 - ... methyl methanesulfonate MeSH D02.455.326.146.100.250 - hepes MeSH D02.455.326.146.100.300 - isethionic acid MeSH D02.455. ...
5-Methoxy-MDA 5-Methyl-MDA Methylbenzodioxolylbutanamine (MBDB) Methylenedioxyamphetamine (MDA) Methylenedioxyethylamphetamine ... 4 (1). Retrieved 8 January 2015. Malamud, Ozer, Yvette; Yuri, Ito (2010-01-01). Encyclopedia of emotion. Greenwood Press. ISBN ... doi:10.1007/978-3-540-68706-1_154. ISBN 9783540686989. Holland, edited by Julie; Metzner, Ralph; Adamson, Sophia (2001). ... 4 (2): 47-49. Retrieved 6 January 2015. Metzner, Ralph (1993). "Letter from Ralph Metzner". Newsletter of the Multidisciplinary ...
... α-methyl derivative of β-phenylethylamine, the 3,4-methylenedioxy derivative of amphetamine, and the N-desmethyl derivative of ... α-Methyl-3,4-methylenedioxy-β-phenylethylamine 1-(3,4-Methylenedioxyphenyl)-2-propanamine 1-(1,3-Benzodioxol-5-yl)-2- ... methylenedioxy)amphetamine". Journal of Medicinal Chemistry. 36 (23): 3700-3706. doi:10.1021/jm00075a027. PMID 8246240. Baggott ... Synthesis and pharmacological activity of some methoxy and/or methyl analogs". Journal of Medicinal Chemistry. 13 (1): 26-30. ...
... which has been synthesized by methylation of MDA using methylating reagents such as methyl iodide. An excess of reagent or a ... 2007 Jul;121(4):303-7. doi:10.1007/s00414-006-0094-x PMID 16636864 Awad T, Belal T, Maher HM, DeRuiter J, Clark CR. GC-MS ... 3,4-Methylenedioxy-N,N-dimethylamphetamine (MDDM) is a lesser-known research chemical. It is also the N,N-dimethyl analog of 3, ... Postmortem distribution of 3,4-methylenedioxy-N,N-dimethyl-amphetamine (MDDM or MDDA) in a fatal MDMA overdose. Int J Legal Med ...
The activity of amphetamine-type stimulants depends on their unsubstituted phenyl ring, alphy methyl group, primary amino group ... Amphetamine-type stimulants contain chemical groups including unsubstituted phenyl ring, a methyl group at the alpha-position, ... benzoic acid and benzyl methyl ketone. The metabolism of ATS may vary from person to person due to genetic polymorphism of the ... 3. Academic Press. pp. 133-168. doi:10.1016/bs.ant.2018.10.006. ISBN 9780128157176. S2CID 87635740. Maurice T, Su TP (November ...
M-ALPHA (N-methyl analogue) Indanorex Phenethylamine Psychedelics, dissociatives and deliriants MDA Entry in PIHKAL v t e ( ... ALPHA (alpha-ethyl-3,4-methylenedioxybenzylamine) is a lesser-known psychedelic drug and a substituted benzylamine. It is also ... It lasts about 3 hours. Very little data exists about the pharmacological properties, metabolism, and toxicity of ALPHA. ... 4-methylenedioxyamphetamine (MDA). ALPHA was first synthesized by Alexander Shulgin. In his book PIHKAL on the MDA page, the ...
... has never been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which ... methylenedioxy)amphetamine". Journal of Medicinal Chemistry. 36 (23): 3700-6. doi:10.1021/jm00075a027. PMID 8246240. "Temporary ... 4 Jun 2013. Retrieved 2013-07-11. (Articles with short description, Short description matches Wikidata, Articles without EBI ... 6-MAPDB (1-(2,3-dihydrobenzofuran-6-yl)-N-methylpropan-2-amine) is a chemical compound which might be an entactogenic drug. It ...
Scientific research has shown that MMDA-2, unlike MMDA, but similarly to 6-methyl-MDA, is only very weak at inducing the ... 5-methylenedioxyamphetamine) is a psychedelic drug of the amphetamine class. It is closely related to MMDA and MDA. Alexander ... 38 (3): 505-12. doi:10.1016/0091-3057(91)90005-M. PMID 1829838. S2CID 2740262. Glennon RA, Yousif M, Naiman N, Kalix P (March ... 26 (3): 547-51. doi:10.1016/0091-3057(87)90164-X. PMID 3575369. S2CID 5890314. Clare BW (2002). "QSAR of benzene derivatives: ...
Methylenedioxyamphetamine (MDA), an analogue and active metabolite of MDMA EA 1299 - EA-1298 (S)-form EA 1302 - 3- ... O-methyl diethyltabun EA 1246 - G-agent S EA 1249 - 2-Methylpropyl methylphosphonofluoridate EA 1250 - Diisopropyl ... 3, "Final Report: Current Health Status of Test Subjects" (1985) Veterans at Risk: Health Effects of Mustard Gas and Lewisite, ... 3, "Final Report: Current Health Status of Test Subjects" (1985) The National Academy of Sciences, which oversees the IOM, sent ...
2-methyl-3-morpholino-1,1-diphenylpropane-carboxylic acid) morpheridine morphine morphine-methobromide morphine-N-oxide ... N-hydroxy-methylenedioxyamphetamine) hydroxypethidine isomethadone ketobemidone levamphetamine levophenacylmorphan ... 1-methyl-4-phenyl-4-piperidinol propionate ester) 4-MTA (4-methylthioamphetamine) 3-methylthiofentanyl metopon moramide ... 1-methyl-4-phenylpiperidine-4-carbonic acid) phenadoxone phenampromide phenazocine phencyclidine phenmetrazine phenomorphan ...
Mibolerone 17α-Methyl-Δ1-dihydrotestosterone Nandrolone Norandrostenediol Norandrostenedione Norbolethone Norclostebol ... Methylenedioxyamphetamine Methylephedrine Methylhexaneamine (dimethylamylamine, DMAA) Modafinil Nikethamide Norfenefrine ... Epitestosterone Ethylestrenol Androstidie Fluoxymesterone Formebolone Furazabol 13α-Ethyl-17a-hydroxygon-4-en-3-one Gestrinone ... 4-Hydroxytestosterone 4-Hydroxy-19-nortestosterone Mestanolone Mesterolone Methandienone Methandriol Methasterone (Superdrol) ...
It is also a monoamine oxidase inhibitor (MAOI), as well as a very potent inhibitor of the enzyme phenylethanolamine N-methyl ... Fuller RW, Mills J, Marsh MM (April 1971). "Inhibition of phenethanolamine N-methyl transferase by ring-substituted alpha- ... "Inhibition of monoamine oxidase action on kynuramine by substrate amines and stereoisomeric α-methyl amines". Biochemical ... 14 (4): 322-5. doi:10.1021/jm00286a012. PMID 5553744. Wu Q, Gee CL, Lin F, Tyndall JD, Martin JL, Grunewald GL, McLeish MJ ( ...
Most commercial root beers have replaced the sassafras extract with methyl salicylate, the ester found in wintergreen and black ... Growth is rapid, particularly with root sprouts, which can reach 1.2 m (3.9 ft) in the first year and 4.5 m (15 ft) in 4 years ... The leaves are alternate, green to yellow-green, ovate or obovate, 10-15 cm (4-6 in) long and 5-10 cm (2-4 in) broad with a ... 20 (4): 586-90. doi:10.1021/tx7000527. ISSN 0893-228X. PMC 2504026. PMID 17362034. "CFR - Code of Federal Regulations Title 21 ...
DOM being short for desoxy methyl, referring to the removal of the Oxygen atom from the Methoxy group on the "4" carbon. 2C-B ( ... 5-methylenedioxyamphetamine) TeMA (2,3,4,5-tetramethoxyamphetamine) Not all of these chemicals are bioassayed in PIHKAL; some ... They are found within the first book of PIHKAL, and are as follows: Mescaline (3,4,5-trimethoxyphenethylamine) DOM (2,5- ... 5-dimethoxy-4-propylthiophenethylamine) All six are now Schedule I controlled substances in the United States. Olivetol List of ...
52 (3-4): 271-80. doi:10.1016/0014-2999(78)90279-0. PMID 729639. Miller RT, Lau SS, Monks TJ (April 1997). "2,5-Bis-(glutathion ... 1991), demonstrated that the major metabolites alpha-methyldopamine (α-Me-DA or HHA) and 3-O-methyl-α-methyldopamine (3-O-Me-α- ... 323 (2-3): 173-80. doi:10.1016/S0014-2999(97)00044-7. PMID 9128836. (Articles with short description, Short description matches ... α-Methyldopamine (α-Me-DA), also known as 3,4-dihydroxyamphetamine (3,4-DHA or HHA), is a research chemical of the ...
Alfa Aesar entry on 2-Nitro-1-phenylpropene , accessed on March 20, 2021 Material Safety Data Sheet trans-β-Methyl-β- ... This is reduced to 3,4-methylenedioxyamphetamine, or MDA, which can be methylated to 3,4-methylenedioxymethamphetamine, or MDMA ... One such reaction is the Knoevenagel condensation of piperonal with nitroethane, yielding 3,4-methylenedioxy-1-phenyl-2- ... 4-Methylenedioxyphenyl-2-Nitropropene From Piperonal, Nitroethane & NaOH] Организация Объединённых Наций (2007). "Синтез ...
Derivatives include compounds such as 1-methylindane and 2-methylindane (where one methyl group is attached to the five carbon ... methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 33 (2): 703-10. doi:10.1021/jm00164a037. PMID 1967651. ( ... where one methyl group is attached to the benzene ring), and various dimethylindanes. Other derivatives can be obtained ... Indane or indan is an organic compound with the formula C6H4(CH2)3. It is a colorless liquid hydrocarbon. It is a petrochemical ...
Methyl-J, also known as 'MDMB' Ethyl-K, also known as 'EBDP' Methyl-K, also known as 'MBDP' and 'UWA-91' IDNNA Iris MDAI MDMAI ... 5-methylenedioxyamphetamine 4-Bromo-3,5-dimethoxyamphetamine EEE EEM EME EMM EDMA EIDA Ethyl-J, also known as 'EBDB' ... N-Methyl-N-isopropyltryptamine, also known as 'MiPT' N-Methyl-N-propyltryptamine, also known as 'MPT' N,N-Diethyltryptamine, ... MMDA-2 5-Methyl-MDA MEE MME MPM DiFMDA 5-APB 6-APB, also known as 'Benzofury' 5-APDB 6-APDB 5-MAPB 5-MAPDB 6-MAPDB, its ...
The chemical structure of MDAI is indirectly derived from that of the illicit drug MDA, but the alpha-methyl group of the alkyl ... methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry. 33 (2): 703-10. doi:10.1021/jm00164a037. PMID 1967651. ... Oberlender R, Nichols DE (December 1990). "(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative stimulus in ... "Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan". European Journal of ...
1-methyl-1-azaspiro[4.5]decan-6-yl)benzamide) Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol), its salts, ... 1-methyl-2-piperidino) ethyl) propionanilide) Propiram (N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide) Benzimidazoles ... 9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine) Camazepam (7-chloro-1,3-dihydro-3-(N,N- dimethylcarbamoyl)-1-methyl- ... 7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione) Clonazepam (5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4- ...
2-Methyl-5-hydroxytryptamine (2-methylserotonin) and quipazine are moderately selective agonists of the 5-HT3 receptor that are ... ISBN 978-3-319-52442-9. PMID 28097528. Lawn W, Barratt M, Williams M, Horne A, Winstock A (2014). "The NBOMe hallucinogenic ... 24 (4): 310-8. PMID 23145389. Hutcheson, J. D., Setola, V., Roth, B. L., & Merryman, W. D. (2011). Serotonin receptors and ... Neuropharmacology, 61(3), 364-381. Zolkowska, D., Rothman, R. B., & Baumann, M. H. (2006). Amphetamine analogs increase plasma ...
Constitutional exchange like methyl shifts, double bond migrations and carbon backbone rearrangements. Detailed kinetics of ... Additional studies have also shown hydrogen isotope effects in the degradation of Methyl tert-butyl ether and Toluene that have ... Combined carbon and hydrogen isotope analysis has been used to test the authenticity of (E)-methyl cinnamate, γ-decalactone and ... Several studies have proved that hydrogen isotopes on the methyl and methylene position of the resulting ethanol is not ...
N-methyl-3,4-methylenedioxyamphetamine , C13H19NO2 , CID 6421392 - structure, chemical names, physical and chemical properties ...
4-methylenedioxymethamphetamine (MDMA) affects the direction and magnitude of the body temperature response, and the degree of ... N-Methyl-3,4-methylenedioxyamphetamine Grants and funding * R01 DA018418/DA/NIDA NIH HHS/United States ... Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques ... The ambient temperature (T(A)) under which rodents are exposed to (+/-)3,4-methylenedioxymethamphetamine (MDMA) affects the ...
N-Methyl-3,4-methylenedioxyamphetamine Grants and funding * ZIA DA000445/ImNIH/Intramural NIH HHS/United States ...
PCP antagonizes the action of glutamate at the N-methyl-D-aspartate receptor, blocking the influx of calcium and inhibiting ... 4, 5] This degradation is cumulative and dose-related. This has led some experts to warn of the possibility of permanent mood ... Psilocybin is found in the following 3 major genera of mushrooms: Psilocybin, Conocybe, and Panaeolus. Often growing on cow ... The effects of psilocybin last approximately 4-6 hours. Hallucinations are common. The mushrooms cause fewer adverse reactions ...
N-methyl-1,3-benzodioxolylbutanamine (MBDB; "Eden"), and 3,4-methylenedioxy-N-methylcathinone (βk-MDMA; "Methylone"). The ... 149 (2-3): 181-92. doi:10.1016/j.forsciint.2004.06.016. PMID 15749360. PiHKAL ("Phenethylamines i Have Known And Loved") by ... ISBN 978-3-03788-700-4. Dr. Matthias Grill, Novel Safrylamine derivates having prodrug properties. Patent WO 2022/053696 Świst ... The base compound of the MDxx class is 3,4-methylenedioxyphenethylamine (MDPEA), and the prototypical agent of this class is 3, ...
... meth-yl] -2-hydroxy-5-methyl-benzaldehyde 2014 Depto. de Quimica - Universidade Federal de Santa Catarina, 88040-900 ... The mol-ecular structure consists of three hy-droxy-benzyl groups and one 2-hy-droxy-5-methyl-benzaldehyde group bonded to the ... In the 2-hy-droxy-5-methyl-benzaldehyde group, an intra-molecular S(6) O-Hcdots, three dots, centeredO hydrogen bond is ... JID: 9602153; 0 (Street Drugs); KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine); OTO: NOTNLM; 2014/06/23 [aheadofprint]; ...
... and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine J Assoc Off Anal Chem 1987 70(6):981-6 ... Toxicity studies showed all of the compounds to have LD50 values similar to N-methyl MDA (MDMA). ... A series of N-alkyl derivatives of 3,4-methylenedioxyamphetamine (MDA) was prepared in an effort to characterize these ... "Synthesis, identification, and acute toxicity of some N-alkyl derivatives of 3,4-methylenedioxyamphetamine". ...
AM-2233((2-iodophenyl)[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-methanone). ... 1-Methyl-4-Phenyl-4-Propionoxypiperidine (MPPP).. 37. 3-Methylfentanyl (N-. [3-methyl-1-(2-phenylethyl)-4-piperidyl]-N- ... 6. Alpha-methylfentanyl (N-[1-(alpha-methyl-betaphenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N- ... Fluoro-AMB: Methyl 2-(1-(fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate. ...
Nichols DE Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA) J ... The 2-methyl derivative 2a and the 5-methyl derivative 2b were found to be more potent and more selective than the parent ... methylenedioxy)amphetamine (MDA)" J Med Chem. 1998 Mar 12;41(6):1001-5. ... "Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)". ...
Raman spectroscopy with far-red excitation has been used to study seized, tableted samples of MDMA (N-methyl-3,4- ... methylenedioxyamphetamine) and related compounds (MDA, MDEA, MBDB, 2C-B and amphetamine sulfate), as well as pure standards of ... 2000 Feb 14;125(3):541-4.. Bell SEJ, Burns DT, Dennis AC, Speers JS. "Rapid Analysis of Ecstasy and Related Phenethylamines in ...
Methyl-DMA · Methyl-DOB · Methyl-J (MBDB) · Methyl-K · Methyl-MA (PMMA) · Methyl-MMDA-2 · MMDA · MMDA-2 · MMDA-3a · MMDA-3b · ... 5-methylenedioxyamphetamine · 2C-B · 3C-BZ · 2C-C · 2C-D · 2C-E · 3C-E · 2C-F · 2C-G · 2C-G-3 · 2C-G-4 · 2C-G-5 · 2C-G-N · 2C-H ... followed by methylation with fresh sodium isopropoxide and methyl iodide, to give the beta-methyl product. This formed the two ... Several people have asked me what I thought about the potential activity of a compound with a methyl group added to DMMDA. One ...
3-benzodioxol-5-yl)butan-2-amine Identifiers CAS number 42542-07-4 ATC code  ? PubChem 129870 ... Kronstrand R. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users. Journal of ... methylenedioxyamphetamine, two widely distributed street drugs. Rapid Communications in Mass Spectrometry. 1998;12(12):779-82. ... Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- ...
... and N-methyl-benzodioxolylbutanamine (MBDB) in urine. These drugs are often encountered in forensic and clinical toxicological ... 4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxymethamphetamine (MDMA, ecstasy), 3,4-methylenedioxy-N-ethylamphetamine ( ...
Explore the 216 possible drugs interactions for 3-Nitrotyrosine and the research papers that mention these interactions. ...
N-Methyl-3,4-methylenedioxyamphetamine (5). *. Substance-Related Disorders (5). *. Analgesics, Opioid (4). ... SA/NPT/A/6/4/2/40. Part of: National Association for the Prevention of Consumption and other forms of Tuberculosis, successor ... SA/NPT/A/6/4/3/9. Part of: National Association for the Prevention of Consumption and other forms of Tuberculosis, successor ... SA/NPT/A/6/4/2/62. Part of: National Association for the Prevention of Consumption and other forms of Tuberculosis, successor ...
The N-methyl derivatives of MDA and BDB, MDMA and MBDB, respectively, and the optical antipodes of these four agents were ... N-methylation of racemic MDA resulted in a decreased ability to release DA, while side chain extension from alpha-methyl to ... 1986;132(2-3):269-76.. Johnson MP, Hoffman AJ, Nichols DE. "Effects of the enantiomers of MDA, MDMA and related analogues on [ ... The primary amines 3,4-methylenedioxyamphetamine (MDA), and 1-(1,3-benzodioxol-5-yl)-2-butanamine (BDB) were measured for ...
N-Methyl-3,4-methylenedioxyamphetamine Preferred Term Term UI T056085. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1995). ... N-Methyl-3,4-methylenedioxyamphetamine Hydrochloride Narrower Concept UI. M0329175. Registry Number. 64057-70-1. Terms. N- ... N-Methyl-3,4-methylenedioxyamphetamine Preferred Concept UI. M0028171. Registry Number. KE1SEN21RM. Related Numbers. 42542-10-9 ... N-Methyl-3,4-methylenedioxyamphetamine. Tree Number(s). D02.092.471.683.152.670. Unique ID. D018817. RDF Unique Identifier. ...
Lyvers, M., Thorberg, F. A., Ellul, A., Turner, J. & Bahr, M., Feb 2010, In: Personality and Individual Differences. 48, 3, p. ... Lincoln, RA., Najman, J., Wilson, P. & Matis, C., 1983, In: Medical Journal of Australia. 1, 8, p. 357-360 3 p.. Research ... Gavin, M., 1 Dec 2004, In: Japanese Studies. 24, 3, p. 323-333 11 p.. Research output: Contribution to journal › Article › ... Matsumoto, M. & Obana, Y., Jun 2001, In: New Zealand Journal of Asian Studies. 3, 1, p. 59-86 27 p.. Research output: ...
2-Methyl-3,4-methylenedioxyamphetamine, 1-(4-Methyl-1,3-benzodioxol-5-yl)propan-2-amine, 2-Me-MDA, 1-(4-Methyl-2H-1,3- ... Explore the structures and analogues of 2-Methyl-MDA, ... Methylenedioxy)amphetamine (MDA). J. Med. Chem., 1 Mar 1998, 41 ... InChI=1S/C11H15NO2/c1-7(12)5-9-3-4-10-11(8(9)2)14-6-13-10/h3-4,7H,5-6,12H2,1-2H3 ... Sáez-Briones, P; Hernández, A. MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: ...
3,4-Methylenedioxy-N-methylamphetamine (MDMA) with the InChIKey SHXWCVYOXRDMCX-UHFFFAOYSA-N. ... CH$NAME: N-Methyl-3,4-methylenedioxyamphetamine. CH$NAME: 1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine. CH$COMPOUND_CLASS: N ... 3,4-Methylenedioxy-N-methylamphetamine (MDMA); LC-ESI-QFT; MS2; CE: 15; R=35000; [M+H]+. Mass Spectrum ... CH$IUPAC: InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3. CH$LINK: CAS 42542-10-9. CH$LINK: ...
N-Methyl-3,4-methylenedioxyamphetamine. Hallucinogens. Physiological Effects of Drugs. Psychotropic Drugs. Serotonin Agents. ... A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2). The safety and scientific validity of this study is ... The SDS is a 3-item scale measuring the severity of disability in the domains of work, family life/home responsibilities and ... 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy may be a potential treatment option for PTSD. MDMA is a ...
Powered by Pure, Scopus & Elsevier Fingerprint Engine™ All content on this site: Copyright © 2024 Elsevier B.V. or its licensors and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the Creative Commons licensing terms apply We use cookies to help provide and enhance our service and tailor content. By continuing you agree to the use of cookies. ...
Pardo, J. S., Jordan, K., Mallari, R., Scanlon, C. & Lewandowski, E., 1 Oct 2013, In: Journal of Memory and Language. 69, 3, p ... Pardo, J. S., 2 Jul 2016, In: Ecological Psychology. 28, 3, p. 171-175 5 p.. Research output: Contribution to journal › Article ... Sternberg, R. J. & Pardo, J., 1 Jan 1998, In: Teaching of Psychology. 25, 4, p. 293-296 4 p.. Research output: Contribution to ... Pardo, J. S., 1 Apr 2006, In: Journal of the Acoustical Society of America. 119, 4, p. 2382-2393 12 p.. Research output: ...
methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate 100% ... Jung, M. E., Wallis, C. J., Gatch, M. B. & Lal, H., 2000, In: Psychopharmacology. 149, 3, p. 235-240 6 p.. Research output: ... Gatch, M. B., Selvig, M. & Forster, M. J., Jul 2005, In: Behavioural pharmacology. 16, 4, p. 261-266 6 p.. Research output: ... Gatch, M. B., Dolan, S. B. & Forster, M. J., 2020, In: Behavioural pharmacology. 31, 4, p. 378-384 7 p.. Research output: ...
N-Methyl-3,4-methylenedioxyamphetamine 100% * Post-Traumatic Stress Disorders 73% * Psychotherapy 72% ... 2021, En: Journal of Clinical Medicine. 10, 4, p. 1-14 14 p., 782.. Producción científica: Contribución a una revista › ... 2021, En: Journal of the National Cancer Institute. 113, 4, p. 371-380 10 p.. Producción científica: Contribución a una revista ... 2022, En: Journal of Cachexia, Sarcopenia and Muscle. 13, 3, p. 1596-1622 27 p.. Producción científica: Contribución a una ...
Cleland, J., Leggett, H., Sandars, J., Costa, M. J., Patel, R. & Moffat, M., 1 Mar 2013, In: Medical Education. 47, 3, p. 242- ... Ott, J. J., Irving, G. & Wiersma, S. T., 17 Dec 2012, In: Vaccine. 31, 1, p. 3-11 9 p.. Research output: Contribution to ... May, S., Chance-Larsen, K., Littlewood, C., Lomas, D. & Saad, M., 1 Sept 2010, In: Physiotherapy. 96, 3, p. 179-190 12 p.. ... Jack, B., Boland, A., Dickson, R., Stevenson, J. & McLeod, C., May 2010, In: European Journal of Cancer Care. 19, 3, p. 293-301 ...
3-methoxyphenyl)propan-1-one, N-tert-Butyl-3-methoxycathinone in book II of TiHKAL: The Continuation. Alexander & Ann Shulgin ... METHYL-L · α-Bu-N-Me-MDPEA · α-Butyl-N-methyl-3,4-methylenedioxyphenethylamine ... ATK-0102 · α-tert-Butyl-N-methyl-3,4-methylenedioxyphenethylamine · α-tBu-N-Me-3,4-MDPEA ... α-Al-N-Me-2,6-DMPEA · α-Allyl-N-methyl-2,6-dimethoxyphenethylamine ...
N-Methyl-3,4-methylenedioxyamphetamine Medicine & Life Sciences 64% * quantification Social Sciences 53% ... 1-3, 30.01.2009, p. 64-68.. Research output: Contribution to journal › Article › peer-review ... N2 - 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a psychoactive drug with abuse liability and neurotoxic potential. ... AB - 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a psychoactive drug with abuse liability and neurotoxic potential. ...
... methyl or dimethyl butanoate, amino-methyl (or dimethyl)-1-oxobutan-2-yl) carboxamide by substitution at the nitrogen atoms of ... 6S, 6aR, 9R, 10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl]acetate ( ... n. Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate (5F-ADB, 5FMDMB-PINACA). ... j. Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate (MMB-CHMICA, AMB-CHMICA). ...
  • The ambient temperature (T(A)) under which rodents are exposed to (+/-)3,4-methylenedioxymethamphetamine (MDMA) affects the direction and magnitude of the body temperature response, and the degree of hypo/hyperthermia generated in subjects can modify the severity of lasting brain changes in 'neurotoxicity' models. (nih.gov)
  • 3,4-Methylenedioxymethamphetamine (MDMA) modulates cortical and limbic brain activity as measured by [H215O]-PET in healthy humans. (researchgate.net)
  • Recent work with noninvasive human brain imaging has started to investigate the effects of 3, 4-methylenedioxymethamphetamine (MDMA) on large-scale patterns of brain activity. (researchgate.net)
  • Toxicity studies showed all of the compounds to have LD50 values similar to N-methyl MDA (MDMA). (erowid.org)
  • Raman spectroscopy with far-red excitation has been used to study seized, tableted samples of MDMA (N-methyl-3,4-methylenedioxyamphetamine) and related compounds (MDA, MDEA, MBDB, 2C-B and amphetamine sulfate), as well as pure standards of these drugs. (erowid.org)
  • The N-methyl derivatives of MDA and BDB, MDMA and MBDB, respectively, and the optical antipodes of these four agents were compared in this paradigm. (erowid.org)
  • Hernández, A. MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology . (isomerdesign.com)
  • This multi-site, double-blind, placebo-controlled, randomized Phase 3 study will assess the efficacy and safety of 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy compared to psychotherapy with placebo in participants diagnosed with at least moderate PTSD. (clinicaltrials.gov)
  • 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy may be a potential treatment option for PTSD. (clinicaltrials.gov)
  • This multi-site, double-blind, placebo-controlled, randomized Phase 3 study will assess the efficacy and safety of MDMA-assisted psychotherapy versus psychotherapy with placebo control in participants diagnosed with at least moderate PTSD. (clinicaltrials.gov)
  • The primary objective of this study is to evaluate the efficacy of MDMA-assisted psychotherapy for PTSD compared to identical psychotherapy with inactive placebo, as measured by change in Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) Total Severity Score from Visit 3 (Baseline) to Visit 19 (18 weeks post Baseline) (Blake et al. (clinicaltrials.gov)
  • 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) is a psychoactive drug with abuse liability and neurotoxic potential. (johnshopkins.edu)
  • Specimen preparation of a recently presented LC-MS assay with electrospray ionization for quantifying MDMA and its main metabolites in squirrel monkey plasma was modified to include acidic hydrolysis to obtain total 3,4-dihydroxymethamphetamine and 4-hydroxy-3-methoxy-methamphetamine. (johnshopkins.edu)
  • It is a precursor in the synthesis of the insecticide PIPERONYL BUTOXIDE and the drug N-methyl-3,4-methylenedioxyamphetamine (MDMA). (selfdecode.com)
  • Trace amounts of street samples of cocaine hydrochloride and N-methyl-3,4-methylenedioxy-amphetamine (MDMA) on natural and synthetic textiles were successfully detected in situ using confocal Raman microscopy. (lincoln.ac.uk)
  • p-Chloroamphetamine (PCA), 3,4-methylenedioxy-methamphetamine (MDMA) and d-fenfluramine pretreatment attenuates d-fenfluramine-evoked release of 5-HT in vivo. (ox.ac.uk)
  • The compound 3,4-methylenedioxymethamphetamine (MDMA), popularly known as 'ecstasy', is the most commonly misused controlled drug after cannabis among young people in Europe. (cambridge.org)
  • Reference Zhou, Tao-Cheng, Segu, Patel and Wang 3 Serotonin transporter is considered to be one of the markers of the integrity of serotonin neurons and has been validated in animal models of MDMA neurotoxicity. (cambridge.org)
  • [3] However it is more commonly known as a metabolite of the N-alkylated analogues MBDB and EBDB which have appeared in street "Ecstasy" pills. (bionity.com)
  • [4] [5] While BDB itself has not been reported as being sold as "Ecstasy", urine analysis of "Ecstasy" users suggest that this drug may have appeared as a street drug, although it is unclear whether the positive urine test for BDB resulted from consumption of BDB itself or merely as a metabolite of MBDB. (bionity.com)
  • Kronstrand R. Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users. (bionity.com)
  • A series of N-alkyl derivatives of 3,4-methylenedioxyamphetamine (MDA) was prepared in an effort to characterize these potential drugs of abuse. (erowid.org)
  • "Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)" J Med Chem . (erowid.org)
  • The analytical properties of these compounds are compared with the structurally similar 3,4-methylenedioxyamphetamine (MDA) derivatives, a popular series of drugs of abuse. (erowid.org)
  • These were removed by filtration, Et2O-washed, and air dried, to give 2.9 g of 2,5-dimethoxy-3,4-methylenedioxyamphetamine hydrochloride (DMMDA) that melted in the 165-175 °C range. (drugwiki.net)
  • A solution of 20 g methylamine hydrochloride in 150 mL hot MeOH was treated with 10.0 g 4-methoxyphenylacetone and stirred magnetically. (drugwiki.net)
  • The 2-methyl derivative 2a and the 5-methyl derivative 2b were found to be more potent and more selective than the parent compound in inhibiting [3H]-serotonin accumulation in rat brain synaptosomal preparations. (erowid.org)
  • The primary amines 3,4-methylenedioxyamphetamine (MDA), and 1-(1,3-benzodioxol-5-yl)-2-butanamine (BDB) were measured for efficacy in release of [3H]serotonin (5-HT) from rat hippocampal slices, and release of [3H]dopamine (DA) from rat caudate nucleus slices. (erowid.org)
  • These can be broadly divided into (i) compounds where the methylenedioxyphenyl ring is retained but the phenethyl portion is modified, or (ii) compounds which retain the 3,4-cyclised amphetamine core common to the MDxx compounds, but have the 1,3-benzodioxole ring replaced by related heterocycles. (wikipedia.org)
  • Compounds of the HMDA series have UV absorption properties similar to the MDAs because both series contain the same 3,4-methylenedioxyphenyl chromophore. (erowid.org)
  • The track record from the comparison of active compounds that are primary amines, and their N-methyl homologues, has shown that, in general, the stimulant component might be maintained, but the "psychedelic" contribution is generally much reduced. (drugwiki.net)
  • Trenbolone (17β-hydroxyestr-4,9,11-trien-3- one) and other substances with a similar chemical structure or similar biological effect(s). (wada-ama.org)
  • Animal studies, prompted by the clandestine synthesis of METHYL-MA, have shown that there is indeed locomotor stimulation and some central effects, but these effects are somehow different than those of a simple amphetamine-like agent. (drugwiki.net)
  • N-methylation of racemic MDA resulted in a decreased ability to release DA, while side chain extension from alpha-methyl to alpha-ethyl completely abolished this activity. (erowid.org)
  • 36. 1-Methyl-4-Phenyl-4-Propionoxypiperidine (MPPP). (flsenate.gov)
  • J , BDB , or 3,4-methylenedioxy-alpha-ethyl- phenethylamine , is a psychedelic drug with a limited history of use in humans. (bionity.com)
  • Garofano L, Santoro M, Patri P, Guidugli F, Bollani T, Favretto D, Traldi P. Ion trap mass spectrometry for the characterization of N-methyl-1- (3,4-methylene-dioxyphenyl)-2-butanamine and N-ethyl-3,4- methylenedioxyamphetamine, two widely distributed street drugs. (bionity.com)
  • These amines are homologues of the N-substituted 3,4-methylenedioxyamphetamines (MDAs). (erowid.org)
  • And as 4-MA is a pretty pushy stimulant with little if any sensory sparkle, why bother with the N-methyl compound at all? (drugwiki.net)
  • 4. Alphacetylmethadol (except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate, or LAAM). (flsenate.gov)
  • The dihydrodiol is one of the metabolites of safrole, and presumably arises from the hydration of the 2, 3-epoxide. (selfdecode.com)
  • Eugenol and its isomer I-methoxy- 2-hydroxy-4-allylbenzene have been detected as minor metabolites in the rat, mouse and man. (selfdecode.com)
  • 4) 'Control' means to add, remove, or change the placement of a drug, substance, or immediate precursor included in Schedules I through VI of this Article. (ncleg.net)
  • Three regioisomeric 3,4-methylenedioxyphenethylamines having the same molecular weight and major mass spectral fragments of equivalent mass have been reported as components of clandestine drug samples in recent years. (erowid.org)
  • In truth, METHYL-MA is a well studied drug, at least in animals. (drugwiki.net)
  • With continued stirring, there appeared yellow crystals of 1-(2,5-dimethoxy-3,4-methylenedioxyphenyl)-2-nitropropene which, after filtering, washing with 50% acetone and air drying, weighed 8.0 g and had a mp of 110-111 °C. (drugwiki.net)
  • 3a) 'Commission' means the Commission for Mental Health, Developmental Disabilities, and Substance Abuse Services established under Part 4 of Article 3 of Chapter 143B of the General Statutes. (ncleg.net)
  • 3. The physical appearance of the tablets, capsules or other finished product containing the substance is substantially identical to a specified controlled substance. (ncleg.net)
  • It is 4-methoxy-N-methylamphetamine or METHYL-MA which, according to the twins, should give the illusion of substance to one's alter ego. (drugwiki.net)
  • 3) 'Bureau' means the Bureau of Narcotics and Dangerous Drugs, United States Department of Justice or its successor agency. (ncleg.net)
  • The drugs 2-, 3-, and 4-methoxy-N-methylamphetamine, 3-methoxy-4,5-methylenedioxy-N-methylamphetamine and 3,4-methylenedioxy-N-methylamphetamine are identified by spectroscopic techniques. (erowid.org)
  • The 1-(3,4-methylenedioxyphenyl)-3-butanamines (HMDAs) are prepared via reductive amination of the corresponding ketone with a series of low molecular weight alkylamines. (erowid.org)
  • Reference Battaglia, Yeh, O'Hearn, Molliver, Kuhar and De Souza 4 - Reference Szabo, McCann, Wilson, Scheffel, Owonikoko and Mathews 6 Studies in rodents and non-human primates suggest long-lasting reductions in SERT availability after single and multiple administrations. (cambridge.org)